NEWS
Dr. Koen Deloose and his vascular team.
Unveiling Bentley's BeFlow: A devoted solution for iliac occlusive diseases
Hechingen, Leipzig, January 28th, 2025. Bentley, a leading manufacturer of balloon expandable covered stents, announces the market launch of its BeFlow iliac covered stent system at the LINC congress in Leipzig, (January 28-30th). It is dedicated to the treatment of iliac occlusive and stenotic diseases and enables physicians to treat patients suffering from arteriosclerosis with a covered stent ensuring safe treatment, long-term patency and durability.
“Our target is to provide a specialized solution for the growing number of patients suffering from diseased iliacs. Bentley has designed the BeFlow covered stent as a focused stent platform addressing stenotic and occluded iliac lesions. Combining all aspects of Bentley covered stent quality, the BeFlow has the potential to become a very competitive alternative in a price-sensitive market segment”, says Martijn Nugteren, Director Sales & Marketing at Bentley. The BeFlow comes in four diameters of 7 to 10 mm and two nominal lengths of 37 and 57 mm. A higher degree of product standardization has a positive impact on production as well as logistic cost, making the BeFlow an affordable solution for the treatment of stenosed iliacs. Martijn Nugteren adds: “Up to now, bare metal stents are still frequently used in heavily stenosed iliac arteries while a covered stent would have been the preferred option. Here, financial aspects influence the decision. With the BeFlow we hope to narrow the cost gap between bare metal stents and covered stents so that patients can be treated with a device that really makes a difference.”
“The BeFlow is a great solution for patients with complex aorto-iliac occlusive disease. When dealing with more simple lesions, Bentley offers an established uncovered balloon expandable stent, the BeSmooth, with the same product features such as a low profile, high visibility and flexibility that we know from the already proven design from the BeGraft. Regarding ease of use during the endovascular intervention, the new BeFlow fulfills all requirements. Particularly, in heavily stenosed or even occluded iliacs, a covered stent is the preferred solution, as it will ensure long-term patency and is in line with the ESVS guidelines for Iliac stenting, where it is stated that covered stents may be considered due to higher patency rates.”, summarized Dr. Koen Deloose, Head of Vascular Surgery AZ Sint-Blasius Hospital Dendermonde in Belgium, who had conducted the “first in man” procedure with a 78-year-old patient suffering from severe claudication.
Together with Bentley’s BeBack crossing catheter and the balloon-expandable uncovered BeSmooth stent, the BeFlow marks an important extension of the company’s portfolio of peripheral solutions.
The BeFlow is CE certificated and will be commercially available as of February 2025. After the market launch, Bentley plans a Post-Market Clinical Follow-up (PMCF) study, led by Dr. Antonella Ruffino, Lugano, Switzerland, as principal investigator.
Visit the Bentley team at Leipzig Interventional Course (LINC) from January 28-30 at booth #103 to learn more about our products.
About Bentley
Founded in 2009 by Lars Sunnanväder and Miko Obradovic, Bentley InnoMed GmbH is based in the medical technology stronghold of Hechingen in Baden-Wurttemberg, Germany. The company develops, manufactures, and markets implants and catheters for the endovascular treatment of peripheral vascular and aortic diseases. The company has since then become a leading global manufacturer and the European market leader for covered stents. The company is part of the Bentley Endovascular Group. Close to 500 employees are committed to the Group’s strong culture of innovation, making Bentley one of the most important employers in the county of Zollernalb and beyond. Based on its product innovations and the development of new markets, the company is on a path of strong growth momentum.
Dr. Koen Deloose and his vascular team.